Clin2
NCT07405372Possibly a fitRecruiting

IDH mutation PET/MRI scan for brain tumors

Glioma

Part of Cancer clinical trials.

This study uses a special type of PET/MRI scan to look for a common genetic change (IDH mutation) in brain tumors (gliomas). The goal is to improve how doctors diagnose and treat these tumors.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You have a glioma (brain tumor) that is suspected, newly diagnosed, or previously treated.
  • You are willing to give written permission to take part in the study.
  • You are not pregnant or breastfeeding.
  • You can safely have an MRI scan (no metal implants, no severe claustrophobia).
  • You have not had more than 50 mSv of radiation from medical tests in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00870129Recruiting
MRI mapping to plan radiation for certain brain tumors

This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.

New York, New York
NCT05700071Recruiting
MRI study of brain tumor genetics

This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.

Paris
NCT07219199Not yet recruiting
Study on IDH-mutant tumor cells in brain tumors

This study looks at leftover tumor cells in people with a type of brain tumor called IDH-mutant glioma. Doctors want to learn how many tumor cells remain after treatment by testing tissue from a biopsy or surgery. This may help improve future care.

New York, New York
NCT07778979Not yet recruiting· Early Phase 1
Imaging study for brain tumors using PET and MRI

This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.

Birmingham, Alabama
NCT07159607Recruiting
PET scan for IDH-mutant brain tumors

This trial uses a special PET scan to see how IDH-mutant gliomas respond to treatment. It may help your doctor better track your tumor's activity.

Vienna
NCT06172595Recruiting· Phase 2
PET scan to tell tumor growth from treatment effects in brain cancer

This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.

Singapore

Hear when a new Glioma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.